A. Shapiro, J. Lakey, E. A. Ryan, G. S. Korbutt, E. Toth et al., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen, N Engl J Med, vol.343, issue.4, pp.230-238, 2000.

S. Lablanche, S. Borot, A. Wojtusciszyn, F. Bayle, R. Tétaz et al., Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL Network, Diabetes Care, vol.38, issue.9, pp.1714-1722, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850555

D. Hirsch, J. Odorico, J. S. Danobeitia, A. R. Rickels, M. R. Hanson et al., Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients, Am J Transplant, vol.12, issue.5, pp.1275-1289, 2012.

M. Brissova and A. C. Powers, Revascularization of transplanted islets: can it be improved?, Diabetes, vol.57, issue.9, pp.2269-2271, 2008.

S. Cabric, J. Sanchez, T. Lundgren, A. Foss, M. Felldin et al., Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation, Diabetes, vol.56, issue.8, pp.2008-2015, 2007.

R. P. Robertson, Islet transplantation as a treatment for diabetes: a work in progress, N Engl J Med, vol.350, issue.7, pp.694-705, 2004.

V. Poitout and R. P. Robertson, An integrated view of beta-cell dysfunction in type-II diabetes, Annu Rev Med, vol.47, pp.69-83, 1996.

S. Bardet, V. Rohmer, D. Maugendre, M. Marre, G. Semana et al., Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus, Diabetologia, vol.34, issue.9, pp.648-654, 1991.

M. R. Rickels, C. Liu, R. D. Shlansky-goldberg, S. A. Soleimanpour, K. Vivek et al., Improvement in b-cell secretory capacity after human islet transplantation according to the CIT07 protocol, Diabetes, vol.62, issue.8, pp.2890-2897, 2013.

M. R. Rickels, S. M. Kong, C. Fuller, C. Dalton-bakes, J. F. Ferguson et al., Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures, Am J Physiol Endocrinol Metab, vol.306, issue.10, pp.1217-1224, 2014.

A. U. Teuscher, D. M. Kendall, Y. F. Smets, J. P. Leone, D. E. Sutherland et al., Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass, Diabetes, vol.47, issue.3, pp.324-330, 1998.

D. A. Baidal, R. N. Faradji, S. Messinger, T. Froud, K. Monroy et al., Early metabolic markers of islet allograft dysfunction, Transplantation, vol.87, issue.5, pp.689-697, 2009.

M. R. Rickels, M. H. Schutta, J. F. Markmann, C. F. Barker, A. Naji et al., b-Cell function following human islet transplantation for type 1 diabetes, Diabetes, vol.54, issue.1, pp.100-106, 2005.

E. A. Ryan, J. Lakey, B. W. Paty, S. Imes, G. S. Korbutt et al., Successful islet transplantation: continued insulin reserve provides long-term glycemic control, Diabetes, vol.51, issue.7, pp.2148-2157, 2002.

R. P. Robertson, L. D. Bogachus, E. Oseid, S. Parazzoli, M. E. Patti et al., Assessment of b-cell mass and a-and b-cell survival and function by arginine stimulation in human autologous islet recipients, Diabetes, vol.64, issue.2, pp.565-572, 2015.

A. Caumo, R. N. Bergman, and C. Cobelli, Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index, J Clin Endocrinol Metab, vol.85, issue.11, pp.4396-4402, 2000.

E. Breda, M. K. Cavaghan, G. Toffolo, K. S. Polonsky, and C. Cobelli, Oral glucose tolerance test minimal model indexes of b-cell function and insulin sensitivity, Diabetes, vol.50, issue.1, pp.150-158, 2001.

C. Cobelli, G. M. Toffolo, D. Man, C. Campioni, M. Denti et al., Assessment of b-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests, Am J Physiol Endocrinol Metab, vol.293, issue.1, pp.1-15, 2007.

A. Mari, O. Schmitz, A. Gastaldelli, T. Oestergaard, B. Nyholm et al., Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects, Am J Physiol Endocrinol Metab, vol.283, issue.6, pp.1159-1166, 2002.

E. Ferrannini, A. Natali, E. Muscelli, P. M. Nilsson, A. Golay et al., Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study, Diabetologia, vol.54, issue.6, pp.1507-1516, 2011.

J. J. Meier, T. Breuer, R. C. Bonadonna, A. Tannapfel, W. Uhl et al., Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans, Diabetologia, vol.55, issue.5, pp.1346-1354, 2012.

I. Aloulou, J. Brun, and J. Mercier, Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test, Metabolism, vol.55, issue.5, pp.676-690, 2006.

S. Borot, N. Niclauss, A. Wojtusciszyn, C. Brault, S. Demuylder-mischler et al., Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network, Transplantation, vol.92, issue.9, pp.1031-1038, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00628808

, Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment (TRIMECO), 2016.

P. Y. Benhamou, J. Oberholzer, C. Toso, L. Kessler, A. Penfornis et al., Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium, Diabetologia, vol.44, issue.7, pp.859-864, 1999.

R. P. Eaton, R. C. Allen, D. S. Schade, K. M. Erickson, and J. Standefer, Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior, J Clin Endocrinol Metab, vol.51, issue.3, pp.520-528, 1980.

E. Van-cauter, F. Mestrez, J. Sturis, and K. S. Polonsky, Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance, Diabetes, vol.41, issue.3, pp.368-377, 1992.

R. N. Bergman, Y. Z. Ider, C. R. Bowden, and C. Cobelli, Quantitative estimation of insulin sensitivity, Am J Physiol, vol.236, issue.6, pp.667-677, 1979.

E. A. Ryan, J. Lakey, R. V. Rajotte, G. S. Korbutt, T. Kin et al., Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol, Diabetes, vol.50, issue.4, pp.710-719, 2001.

M. R. Rickels, R. Mueller, K. L. Teff, and A. Naji, b-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants, J Clin Endocrinol Metab, vol.95, issue.3, pp.1238-1246, 2010.

E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli et al., Five-year follow-up after clinical islet transplantation, Diabetes, vol.54, issue.7, pp.2060-2069, 2005.

C. J. Greenbaum, T. Mandrup-poulsen, P. F. Mcgee, T. Battelino, B. Haastert et al., Type 1 Diabetes Trial Net Research GroupEuropean C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes, Diabetes Care, vol.31, issue.10, pp.1966-1971, 2008.

E. Christiansen, L. L. Kjems, A. Vølund, A. Tibell, C. Binder et al., Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients, Am J Physiol, vol.274, issue.4, pp.716-725, 1998.

A. Mari, A. Tura, A. Natali, M. Laville, M. Laakso et al., Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia, vol.53, pp.749-756, 2010.